Integra LifeSciences Holdings Corporation (IART)

IART Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-495.8	-516.47	-6.94	67.74	180.55	169.08
Depreciation & Amortization	153.07	151.83	140.89	123.51	118.3	119.84
Stock-Based Compensation	21.88	18.58	24.38	20.14	27.73	36.21
Other Adjustments	175.01	430.18	2.06	10.13	-22.69	-30.86
Change in Receivables	-8.29	-0.49	7.4	4.59	-33.91	7.27
Changes in Inventories	-37.39	-46.76	-28.15	-59.77	-29.12	5.37
Changes in Accounts Payable	25.54	26.72	-2.67	-20.23	17.34	32.87
Changes in Unearned Revenue	2.53	3.4	3.54	0.13	4.27	0.03
Changes in Other Operating Activities	-22.09	-16.62	-11.12	-6.29	1.99	-27.38
Operating Cash Flow	71.44	50.38	129.38	139.96	264.47	312.43
Operating Cash Flow Growth	-30.21%	-61.06%	-7.56%	-47.08%	-15.35%	53.28%
Capital Expenditures	-67.36	-81.44	-104.42	-66.87	-42.34	-48.02
Sale of Property, Plant & Equipment	-	-	-	-	-	0
Purchases of Intangible Assets	-	-14.2	-9.95	-	-4.74	-0.06
Purchases of Investments	-1.5	-8.5	-49	-32.69	-51.51	-
Proceeds from Sale of Investments	7	7	54.5	-	-	-
Payments for Business Acquisitions	-	-	-277.81	-	11.15	-303.91
Proceeds from Business Divestments	-	-	-	-	23.96	190.47
Other Investing Activities	-10.49	-10.92	-4.13	5.38	4.91	0.08
Investing Cash Flow	-86.99	-108.06	-390.81	-94.18	-58.58	-161.44
Long-Term Debt Issued	710.8	720.7	486.5	165.1	40.75	25.5
Long-Term Debt Repaid	-115.25	-669.89	-187.13	-110.6	-148.55	-125.5
Net Long-Term Debt Issued (Repaid)	595.55	50.81	299.37	54.5	-107.8	-100
Issuance of Common Stock	0.76	0.96	6.4	4.32	5.47	6.82
Repurchase of Common Stock	-0.11	-0.22	-52.47	-275	-125	-
Net Common Stock Issued (Repurchased)	0.65	0.74	-46.07	-270.68	-119.54	6.82
Other Financing Activities	-17.92	-23.21	-15.43	-13.74	-24.62	-5.05
Financing Cash Flow	1.26	28.34	237.86	-229.93	-251.95	-98.23
Effect of Exchange Rate Changes on Cash and Cash Equivalents	12	18.02	-6.46	3.89	-10.72	-9.48
Net Cash Flow	-2.3	-11.33	-30.03	-180.26	-56.79	43.28
Free Cash Flow	4.08	-31.05	24.96	73.09	222.13	264.41
Free Cash Flow Growth	-	-	-65.84%	-67.09%	-15.99%	60.30%
FCF Margin	0.25%	-1.90%	1.55%	4.74%	14.26%	17.14%
Free Cash Flow Per Share	0.05	-0.40	0.32	0.91	2.66	3.09
Levered Free Cash Flow	154.05	-428.52	290.5	92.72	143.19	151.79
Unlevered Free Cash Flow	-377.23	-415.05	8.89	63.67	272.12	238.05

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q